Last update :
21/02/2024
References   References 4720  
Type : Manufacturer

Research teams :
Authors :
Title : Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
Reference : Paratek Pharmaceuticals 2021

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionCalcium chloride Electrolyte
Incompatible + InjectionOmadacycline
InjectionCalcium glucoheptonate Electrolyte
Incompatible + InjectionOmadacycline
InjectionCalcium gluconate Electrolyte
Incompatible + InjectionOmadacycline
InjectionFolinate calcium Cytoprotective
Incompatible + InjectionOmadacycline
InjectionLevofolinate calcium Cytoprotective
Incompatible + InjectionOmadacycline
InjectionMagnesium chloride Electrolyte
Incompatible + InjectionOmadacycline
InjectionMagnesium sulfate Electrolyte
Incompatible + InjectionOmadacycline
InjectionOmadacycline Antibiotic
Stability in solutions Not specified NaCl 0,9% or Glucose 5% 1 & 2 mg/mL 2-8°C Not specified
7 Day
Stability in solutions Not specified NaCl 0,9% or Glucose 5% 1 & 2 mg/mL 25°C Not specified
24 Hour
Incompatible + InjectionCalcium chloride
Incompatible + InjectionCalcium glucoheptonate
Incompatible + InjectionCalcium gluconate
Incompatible + InjectionFolinate calcium
Incompatible + InjectionLevofolinate calcium
Incompatible + InjectionMagnesium chloride
Incompatible + InjectionMagnesium sulfate

  Mentions Légales